The Claim
In bovine hepatocytes, exposure to sodium acetate at concentrations of 3.6–7.2 mM is associated with reduced expression and transcriptional activity of SREBP-1c and ChREBP, transcription factors involved in promoting lipogenesis, with decreases in mRNA and protein levels occurring in a dose-dependent manner; this effect is reversed by inhibition of AMPKα, suggesting that acetate suppresses lipogenic pathways through AMPK signaling in these cells.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When cow liver cells are exposed to certain levels of a substance called acetate, it seems to turn down the activity of genes that tell the cell to make fat — and this might happen through a specific cellular switch called AMPK.
See the scientific wording
In bovine hepatocytes, exposure to 3.6–7.2 mM sodium acetate is associated with reduced expression and transcriptional activity of SREBP-1c and ChREBP, two transcription factors that promote fat synthesis, with mRNA and protein levels decreasing in a dose-dependent manner and being reversed by AMPKα inhibition, indicating a link between acetate, AMPK signaling, and suppression of lipogenic pathways in these cells.
What the research says
1 studyThe study shows that acetate reduces fat-making genes in cow liver cells by turning on a switch called AMPK, and this effect goes away if you block that switch—just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.